Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-049015
Filing Date
2022-09-07
Accepted
2022-09-07 16:26:53
Documents
1
Period of Report
2022-09-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 24061
  Complete submission text file 0001209191-22-049015.txt   25376
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 - 3650 GILMORE WAY BURNABY A0 V5G 48W
Business Address
AULIN SHERRY (Reporting) CIK: 0001862144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 221231461